These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 16352693

  • 1. Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity.
    White HD, Ahmad AM, Durham BH, Chandran S, Patwala A, Fraser WD, Vora JP.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):913-9. PubMed ID: 16352693
    [Abstract] [Full Text] [Related]

  • 2. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 3. PTH circadian rhythm and PTH target-organ sensitivity is altered in patients with adult growth hormone deficiency with low BMD.
    White HD, Ahmad AM, Durham BH, Peter R, Prabhakar VK, Corlett P, Vora JP, Fraser WD.
    J Bone Miner Res; 2007 Nov; 22(11):1798-807. PubMed ID: 17645402
    [Abstract] [Full Text] [Related]

  • 4. Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients.
    White HD, Ahmad AM, Syed AA, Clewes A, Peter R, Vora JP, Fraser WD.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):516-26. PubMed ID: 15049968
    [Abstract] [Full Text] [Related]

  • 5. Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiency.
    White HD, Ahmad AM, Durham BH, Joshi AA, Fraser WD, Vora JP.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):726-36. PubMed ID: 21252245
    [Abstract] [Full Text] [Related]

  • 6. Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency.
    Ahmad AM, Hopkins MT, Fraser WD, Ooi CG, Durham BH, Vora JP.
    Bone; 2003 Feb; 32(2):170-9. PubMed ID: 12633789
    [Abstract] [Full Text] [Related]

  • 7. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC, Rossi A, Martinelli CE, Machado HR, Moreira AC.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [Abstract] [Full Text] [Related]

  • 8. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
    Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone replacement is important for the restoration of parathyroid hormone sensitivity and improvement in bone metabolism in older adult growth hormone-deficient patients.
    White HD, Ahmad AM, Durham BH, Patwala A, Whittingham P, Fraser WD, Vora JP.
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3371-80. PubMed ID: 15741264
    [Abstract] [Full Text] [Related]

  • 10. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.
    Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5650-5. PubMed ID: 14671148
    [Abstract] [Full Text] [Related]

  • 11. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR, Toogood AA, Veldhuis JD, Thorner MO, Shalet SM.
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [Abstract] [Full Text] [Related]

  • 12. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC, Lugao HB, Pereira MC, Machado HR, Castro Md, Moreira AC.
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [Abstract] [Full Text] [Related]

  • 13. Alteration of the circadian rhythm of intact parathyroid hormone following a 96-hour fast.
    Fraser WD, Logue FC, Christie JP, Cameron DA, O'Reilly DS, Beastall GH.
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):523-8. PubMed ID: 8187320
    [Abstract] [Full Text] [Related]

  • 14. Biochemical assessment of bone formation and resorption in acromegaly.
    Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR.
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1452-7. PubMed ID: 8501150
    [Abstract] [Full Text] [Related]

  • 15. Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women.
    Heshmati HM, Riggs BL, Burritt MF, McAlister CA, Wollan PC, Khosla S.
    J Clin Endocrinol Metab; 1998 Mar; 83(3):751-6. PubMed ID: 9506720
    [Abstract] [Full Text] [Related]

  • 16. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
    Serri O, Beauregard C, Hardy J.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU, Post KD, Powell JS, Wardlaw SL.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [Abstract] [Full Text] [Related]

  • 18. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
    Sucunza N, Barahona MJ, Resmini E, Fernández-Real JM, Ricart W, Farrerons J, Rodríguez Espinosa J, Marin AM, Puig T, Webb SM.
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [Abstract] [Full Text] [Related]

  • 20. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, Pileri M, Guglielmi G, Di Giorgio A, Modoni S, Fusilli S, Di Cerbo A, Liuzzi A.
    J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.